Middle East & Africa Diabetes Care Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and End User

The MEA diabetes care devices market is expected to grow from US$ 1,828.78 million in 2022 to US$ 2,551.55 million by 2028; it is estimated to grow at a CAGR of 4.3% from 2022 to 2028.

The emerging markets in the developing countries provide better opportunities for major players to expand their business. Many diabetes care device market players are focusing on the emerging markets in the MEA region due to the increasing prevalence of diabetes and the growing use of diabetes care devices. In emerging countries, medical science has grown rapidly in the past few decades. Furthermore, diabetes treatment has become so popular and common that people are traveling to developing countries for treatment. This is due to excessively high expenses for healthcare in other countries. For instance, health travelers who visit developing countries for medical reasons save 65-80% on health costs compared to the cost in developed countries. Due to several other factors, diabetes treatment has become very cheap in developing countries. Further, government authorities in countries in the region are focusing on strengthening their medical tourism sector, thereby maximizing the flow of revenue. Therefore, the rising medical tourism in developing nations is anticipated to provide lucrative growth opportunities to players operating in the diabetes care devices market during the forecast period across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA diabetes care devices market. The MEA diabetes care devices market is expected to grow at a good CAGR during the forecast period.

MEA Diabetes Care Devices Market Segmentation

The MEA diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further segmented into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is categorized into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the MEA diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the MEA diabetes care devices market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The UAE would dominate the market in 2022.

B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the MEA diabetes care devices market.